Multiple drug-resistant (MDR) cancers have elevated glucosylceramide synthase (GCS) and P-glycoprotein, and GCS promoter activity is 15-fold higher in MCF-7-AdrR cells than in MCF-7 cells [13]. The gene discussed is ABCB1; the disease is cancer.